Compania Introductora de Buenos Aires SA
BCBA:INTR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Compania Introductora de Buenos Aires SA
BCBA:INTR
|
AR |
|
S
|
Shanghai Aerospace Automobile Electromechanical Co Ltd
SSE:600151
|
CN |
|
Gelum Resources Ltd
OTC:GMRCF
|
CA |
|
Q BioMed Inc
OTC:QBIO
|
US |
Balance Sheet
Balance Sheet Decomposition
Compania Introductora de Buenos Aires SA
Compania Introductora de Buenos Aires SA
Balance Sheet
Compania Introductora de Buenos Aires SA
| Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
16
|
17
|
30
|
42
|
35
|
178
|
115
|
130
|
78
|
418
|
|
| Cash |
0
|
0
|
0
|
0
|
35
|
178
|
115
|
130
|
78
|
418
|
|
| Cash Equivalents |
16
|
17
|
30
|
42
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
4
|
4
|
6
|
38
|
87
|
48
|
218
|
267
|
334
|
1 058
|
|
| Total Receivables |
56
|
92
|
140
|
195
|
459
|
712
|
1 244
|
2 059
|
2 002
|
3 384
|
|
| Accounts Receivables |
48
|
79
|
116
|
164
|
369
|
565
|
931
|
1 473
|
1 521
|
2 472
|
|
| Other Receivables |
8
|
13
|
24
|
32
|
90
|
148
|
313
|
587
|
482
|
912
|
|
| Inventory |
44
|
73
|
81
|
116
|
393
|
488
|
770
|
1 465
|
1 669
|
3 430
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
27
|
35
|
102
|
160
|
108
|
187
|
|
| Total Current Assets |
119
|
186
|
258
|
392
|
1 002
|
1 462
|
2 449
|
4 082
|
4 192
|
8 476
|
|
| PP&E Net |
51
|
53
|
60
|
80
|
589
|
845
|
1 136
|
1 920
|
1 811
|
3 741
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
21
|
22
|
62
|
111
|
106
|
225
|
|
| Goodwill |
0
|
0
|
0
|
0
|
32
|
24
|
25
|
28
|
17
|
17
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
18
|
28
|
23
|
0
|
|
| Long-Term Investments |
2
|
1
|
1
|
1
|
25
|
36
|
54
|
76
|
76
|
163
|
|
| Other Long-Term Assets |
11
|
4
|
8
|
0
|
5
|
19
|
48
|
216
|
92
|
375
|
|
| Other Assets |
0
|
0
|
0
|
0
|
32
|
24
|
25
|
28
|
17
|
17
|
|
| Total Assets |
184
N/A
|
245
+33%
|
329
+34%
|
474
+44%
|
1 674
+253%
|
2 409
+44%
|
3 791
+57%
|
6 459
+70%
|
6 317
-2%
|
12 998
+106%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
27
|
47
|
63
|
76
|
223
|
339
|
477
|
835
|
683
|
1 317
|
|
| Accrued Liabilities |
13
|
18
|
23
|
35
|
81
|
88
|
151
|
235
|
221
|
664
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
9
|
8
|
29
|
109
|
90
|
65
|
208
|
246
|
921
|
|
| Other Current Liabilities |
11
|
14
|
30
|
48
|
90
|
119
|
264
|
463
|
354
|
479
|
|
| Total Current Liabilities |
53
|
88
|
124
|
187
|
503
|
636
|
956
|
1 740
|
1 504
|
3 381
|
|
| Long-Term Debt |
4
|
3
|
5
|
5
|
53
|
45
|
55
|
77
|
47
|
129
|
|
| Deferred Income Tax |
1
|
1
|
0
|
1
|
0
|
2
|
0
|
0
|
0
|
43
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
1
|
27
|
38
|
61
|
116
|
218
|
|
| Other Liabilities |
2
|
2
|
2
|
0
|
0
|
0
|
25
|
37
|
15
|
0
|
|
| Total Liabilities |
60
N/A
|
94
+57%
|
131
+39%
|
193
+47%
|
557
+188%
|
711
+28%
|
1 075
+51%
|
1 915
+78%
|
1 682
-12%
|
3 770
+124%
|
|
| Equity | |||||||||||
| Common Stock |
58
|
63
|
69
|
81
|
1 044
|
1 555
|
2 335
|
3 830
|
3 830
|
121
|
|
| Retained Earnings |
66
|
88
|
129
|
200
|
74
|
143
|
382
|
715
|
805
|
972
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8 134
|
|
| Total Equity |
124
N/A
|
150
+21%
|
198
+31%
|
281
+42%
|
1 117
+298%
|
1 698
+52%
|
2 717
+60%
|
4 544
+67%
|
4 634
+2%
|
9 228
+99%
|
|
| Total Liabilities & Equity |
184
N/A
|
245
+33%
|
329
+34%
|
474
+44%
|
1 674
+253%
|
2 409
+44%
|
3 791
+57%
|
6 459
+70%
|
6 317
-2%
|
12 998
+106%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
121
|
|